BioXcel Therapeutics (BTAI) Short term Debt (2018 - 2026)
BioXcel Therapeutics (BTAI) recorded quarterly Short term Debt of $22.4 million in Q1 2026, down 10.03% quarter-over-quarter from $24.9 million in Q4 2025, and up 299.98% on a YoY basis from $5.6 million in Q1 2025.
BioXcel Therapeutics (BTAI) Short term Debt (2018 - 2026) Analysis & Trends
BioXcel Therapeutics' Short term Debt history runs 8 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- In Q1 2026, Short term Debt rose 299.98% year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (up 299.98% YoY), while the FY2025 annual figure was $24.9 million, changed N/A from the prior year.
- Short term Debt was $22.4 million for Q1 2026 at BioXcel Therapeutics, down from $24.9 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $24.9 million in Q4 2025 to a low of $56000.0 in Q1 2022.
- Historically, Short term Debt has averaged $7.0 million across 4 years, with a median of $792000.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Short term Debt surged 74.68% in 2022, then surged 578.57% in 2023.
- A 4-year view of Short term Debt shows it stood at $422000.0 in 2022, then soared by 72.99% to $730000.0 in 2023, then soared by 3315.21% to $24.9 million in 2025, then decreased by 10.03% to $22.4 million in 2026.
- The last three Short term Debt figures came in at $22.4 million (Q1 2026), $24.9 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | BioXcel Therapeutics | 25.46 Mn | 25.46 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.43 Mn |
| Dec 31, 2025 | 24.93 Mn |
| Sep 30, 2025 | 16.82 Mn |
| Jun 30, 2025 | 11.22 Mn |
| Mar 31, 2025 | 5.61 Mn |
| Sep 30, 2023 | 730,000.00 |
| Jun 30, 2023 | 854,000.00 |
| Mar 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 422,000.00 |
| Sep 30, 2022 | 269,000.00 |
| Jun 30, 2022 | 296,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 154,000.00 |
| Jun 30, 2021 | 106,000.00 |
| Dec 31, 2020 | 157,000.00 |
| Sep 30, 2020 | 208,000.00 |
| Dec 31, 2019 | 64,000.00 |
| Mar 31, 2018 | 13,000.00 |